Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Basic Science: Emerging Targets

  • You have access
    In vivo distribution of human brain aromatase with [11C]vorozole
    Anat Biegon, Sung Won Kim, Jean Logan, David Schlyer, Frank Telang, Gene-Jack Wang and Joanna Fowler
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 103;
  • You have access
    Alpha2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse
    Axel Rominger, Björn Wängler, Peter Bartenstein and Paul Cumming
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 105;
  • You have access
    Initial PET evaluation of [F-18]fluoro-HEAT for central alpha-1 noradrenergic receptor imaging
    Eric Petrie, John Grierson, Donna Cross, Atsushi Obata, Barbara Lewellen and Satoshi Minoshima
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 107;
  • You have access
    Imaging kappa opioid receptor in humans with a novel antagonist tracer, [11C]LY2795050
    Yiyun Huang, Wendol Williams, Giampaolo Tomasi, Ming-Qiang Zheng, Joseph Olsen, Mike Tabriz, Yu-Shin Ding, Richard Carson, Johannes Tauscher and Alexander Neumeister
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 102;
  • You have access
    Proof-of-concept in vivo PET studies to evaluate inhibition of brain aromatase binding of [11C]vorozole by nicotine administration in female baboons
    Sung Won Kim, Anat Biegon, Jean Logan, Jacob Hooker, Lisa Muench and Joanna Fowler
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 104;
  • You have access
    Age-related olfactory loss is associated with nigrostriatal dopaminergic degeneration
    Nicolaas Bohnen, Martijn Muller, Hiroto Kuwabara and Stephanie Studenski
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 106;
  • You have access
    Kinetic analysis in human brain of 11C-(R)-rolipram, a PET tracer of the cAMP cascade: Test-retest study and the use of an image-derived input function
    Paolo Zanotti-Fregonara, Sami Zoghbi, Jeih-San Liow, Jinsoo Hong, Ronald Boellaard, Victor Pike, Robert Innis and Masahiro Fujita
    Journal of Nuclear Medicine May 1, 2010, 51 (supplement 2) 108;
SNMMI

© 2025 SNMMI

Powered by HighWire